EMEA-003220-PIP01-22-M01 - paediatric investigation plan

milvexian
PIPHuman

Key facts

Active Substance
milvexian
Therapeutic area
Vascular disorders
Decision number
P/0092/2024
PIP number
EMEA-003220-PIP01-22-M01
Pharmaceutical form(s)
  • Age-appropriate oral dosage form
  • Film-coated tablet
Condition(s) / indication(s)
Prevention of thromboembolism in patients with cardiovascular diseases
Route(s) of administration
Oral use
Contact for public enquiries

Janssen Cilag International NV

Tel. +3214602111
E-mail: contact@Janssen-emea.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page